quintiles | pharmaphorum

Tuesday 5 November 2024

Channels

Content type

Categories

Categories

Sort by

Order

quintiles

Partner Content

Cancer attacked by T cells 600

Partner Content

The next step in the fight against cancer: Making CAR-T a vi...

Four years ago, Emily Whitehead, who was just seven years old at the time, inadvertently became headline news as her previously incurable acute lymphoblastic leukaemia (ALL) moved into remission an

Partner Content

Drugs-generic-2

Partner Content

Giving drug candidates the greatest chance for success

With the advent of new targeted treatments and immunotherapies, Quintiles has provided clinical services for over 700 phase 1 and phase 2 oncology studies since 2011.

Views & Analysis

Cancer-cell

Immuno-oncology: how to keep ahead in a fast-moving field

In the last two years, the first PD-1 checkpoint inhibitor drugs to reach patients have launched a revolution in cancer care.

Partner Content

Commuter Business People Cityscape Corporate Travel Concept

Partner Content

VIDEO: Streamlining the process of patient enrollment

Ever more-specific cancer medicines carry the advantage of more personalised treatments for those with the disease.

Partner Content

Packaged Pills in aluminium blisters stacked on each other

Partner Content

Ensuring a more informed and effective oncology drug develop...

The rush to discover the next big frontier in cancer medicine is more evident than it ever has been since the introduction of targeted therapies.

Partner Content

Q webinar main

Partner Content

On Demand: The Top 5 Challenges in Immuno-Oncology Trials

In the battle against cancer, immunotherapy is proving to be one of the most promising avenues of research.